Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden
Background
The presence or development of thrombus during percutaneous coronary intervention (PCI) is associated with poor prognosis.
Aim
This multicenter registry aimed to assess the ClearWay™ (CW) perfusion catheter in reduction of thrombus burden and improvement of the coronary flow during PCI.
Aim
This multicenter registry aimed to assess the ClearWay™ (CW) perfusion catheter in reduction of thrombus burden and improvement of the coronary flow during PCI.
Methods
Utility of the CW perfusion catheter was assessed in patients who presented with intracoronary thrombus and were subjected to PCI. Data were collected by online survey from 15 US sites. Angiographic assessment of the coronary thrombus burden and the coronary flow after intracoronary infusion of glycoprotein (GP) IIb/IIIa inhibitors via the CW catheter was performed at baseline, immediately after infusion, and at the end of the procedure.
Only gold members can continue reading. Log In or Register to continue
Nov 16, 2017 | Posted by drzezo in CARDIOLOGY | Comments Off on Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden